v3.26.1
RESTRICTED STOCK AND WARRANTS (Tables)
3 Months Ended
Mar. 31, 2026
Equity [Abstract]  
Schedule of unvested restricted stock awards
               
          Weighted -  
          Average  
    Number of     Grant  
    Award Shares     Date Fair Value  
             
Unvested at December 31, 2025     70,000     $ 1.04  
                 
Granted     -       -  
                 
Vested     -       -  
                 
Forfeited     -       -  
                 
Balance at March 31, 2026     70,000     $ 1.04  
Schedule of unvested restricted stock units
               
          Weighted -  
          Average  
    Number of     Grant  
    Unit Shares     Date Fair Value  
Unvested at December 31, 2025     232,801     $ 1.32  
                 
Granted     -       -  
                 
Vested     (70,773 )     1.70  
                 
Forfeited     -       -  
                 
Balance at March 31, 2026     162,028     $ 1.13  
Schedule of unvested performance restricted stock units
               
          Weighted -  
          Average  
    Number of     Number of  
    Unit Shares     Unit Shares  
Unvested at December 31, 2025     1,321,591     $ 1.15  
                 
Granted     -       -  
                 
Forfeited/Cancelled     (168,183 )     1.55  
                 
Balance at March 31, 2026     1,153,408     $ 1.10  
Schedule of warrants outstanding
                               
    Number of
Warrant Shares
   

Weighted-

Average

Exercise

Price

   

Weighted -

Average

Remaining

Contractual

Term

(in years)

   

Aggregate

Intrinsic

Value

(in thousands)(1)

 
Balance as of December 31, 2025     1,555,207       3.95       4.4          
                                 
Issued     -       -                  
                                 
Exercised       -     -                  
                                 
Expired     -       -                  
                                 
Balance as of March 31, 2026     1,555,207     $ 3.95       4.1          
                                 
Exercisable as of March 31, 2026     1,555,207     $ 3.95       4.1     $ -  

 

(1)The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying warrants and the closing stock price of $0.81 for our common stock on March 31, 2026.